PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3071/9/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk
The PMCPA Director initiated a complaint (under Paragraph 5.1 of the Constitution and Procedure) after a BMJ paper (Goldacre et al, 12 Sept 2018) ranked sponsors’ compliance with posting results …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3051/6/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Alexion
A UK health professional complained about a LinkedIn post appearing in their feed from Alexion Pharmaceuticals, linking to a press release about ALXN1210 (PNH) and EU regulatory submission.The comp…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3056/8/18
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
An ex-GSK representative complained about (1) GSK’s relationship with a named practice-based pharmacist and (2) a device-use claim in digital sales aids for Relvar Ellipta, Anoro Ellipta and Trel…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3059/8/18
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
An anonymous, non-contactable complainant (appearing to be a Lundbeck employee) complained about: (1) the product section of Lundbeck’s UK website and (2) certification of promotional materials u…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3063/9/18
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Dr Falk Pharma
Dr Falk Pharma UK made a video (2015) with a third party for use on the NHS Alliance website for 12 months.The video discussed inflammatory bowel disease and treatment, included a patient case stud…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3106/10/18
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag Limited made a voluntary admission that a Zytiga (abiraterone) advertisement (ref PHGB/ZYT/0716/0009(1)) was published twice with out-of-date prescribing information (PI).The ad appea…
Clauses: 4.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3107/10/18
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo website product
A UK health professional complained that pages on Daiichi-Sankyo’s website promoted prescription-only medicines (POMs) to the public.The complainant said the site did not separate patient and hea…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3111/10/18
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Pfizer
A contactable complainant (a concerned UK health professional) alleged prescribing information (PI) on Pfizer’s PfizerPro website for Xeljanz (tofacitinib), Sutent (sunitinib) and Champix (vareni…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3126/11/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Alliance Pharmaceuticals
A UK health professional complained about an Alliance Pharmaceuticals LinkedIn post announcing the UK launch of Xonvea (doxylamine succinate 10mg/pyridoxine hydrochloride 10mg) for nausea and vomit…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3127/12/18
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
MSD
Merck Sharp & Dohme (MSD) voluntarily admitted an advertisement for Keytruda (pembrolizumab) did not contain prescribing information.The material was created and certified for use in a congress…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3132/12/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (described as a concerned health professional) complained about advertisements on Facebook and Twitter for meetings allegedly sponsored by pharmaceutical c…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3102/9/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Lilly
A BMJ paper (Goldacre et al, published online 12 September 2018) assessed whether sponsors posted due clinical trial results to the EU Clinical Trials Register (EUCTR) within the European Commissio…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3021/2/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Shire
An anonymous complainant raised a concern about a meeting advertised on LinkedIn.The company involved was Shire.The case was considered under the PMCPA complaints process.
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3010/1/18
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo ruled in breach for omitting key SPC warning in Lixiana (edoxaban) promotional guides
Bristol-Myers Squibb and Pfizer (the Alliance) complained about Daiichi-Sankyo’s promotion of Lixiana (edoxaban), a DOAC for NVAF. The Alliance alleged a consistent omission in promotional materi…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3025/3/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A member of the public made a complaint concerning the promotion of Nexplanon.The complaint was received on 13 March 2018.The case was considered under the ABPI Code of Practice 2016.
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3019/2/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Boehringer Ingelheim
An anonymous complainant raised a concern about a meeting advertised on LinkedIn.The company involved was Boehringer Ingelheim.The case was considered under the ABPI Code of Practice (Applicable Co…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3020/2/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Lilly
An anonymous complainant raised a concern about a meeting advertised on LinkedIn.The company involved was Lilly.The case was assessed under the ABPI Code of Practice 2016.
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3138/12/18
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Indivior
An ex-employee alleged Indivior did not disclose 2017 payments to health professionals, donations or sponsorships in the UK (and referenced missing historic website disclosures).Indivior said it ha…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3013/1/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca employee complaint
An anonymous, non-contactable complainant (described as an AstraZeneca UK marketing company employee) alleged AstraZeneca’s global functions did not receive appropriate ABPI Code training and tha…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2927/1/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
BBC ‘landmark’ headline for unlicensed ocrelizumab trials
An anonymous, non-contactable complainant challenged a BBC website article (22 Dec 2016) titled ‘Multiple sclerosis drug “a landmark”’ about two Phase III trials of Roche’s unlicensed med…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2935/2/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sunovion
An anonymous ex-employee alleged a regional business manager (RBM) encouraged sales staff to pressure customers to prescribe Latuda (lurasidone) by suggesting prescribers could be sued if Latuda wa…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2926/1/17
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Stirling Anglian
A pharmaceutical physician complained that Stirling Anglian’s health professional website described Stirlescent (naproxen effervescent tablets) and theiCal-D3 (1000mg/880IU chewable tablet) as �…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2925/1/17
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer websites
A health professional complained about Pfizer websites, alleging out-of-date prescribing information (PI) across multiple items.Items cited: Vfend (voriconazole) leavepiece (ref VFE1771), Tygacil (…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2950/4/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Tor Generics
A health professional complained about a Tor Generics advertisement in The Big Issue (20–26 March 2017), a magazine sold to the general public.The ad included pack shots of Vitamin D3 capsules, V…
Clauses: NONE
2017 🔒 Subscribe
← Prev 17 18 19 20 21 22 23 Next → Page 20 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews